Gallbladder disease; History of hypersensitivity to Fenofibrate, including severe skin rashes (eg. Stevens-Johnson syndrome, toxic epidermal necrolysis); Liver disease, active, including primary biliary cirrhosis and unexplained persistent liver function abnormality; Nursing mothers; Severe renal dysfunction, including patients receiving dialysis.